Regenxbio (RGNX) Selling, General & Administrative (2014 - 2026)
Regenxbio's Selling, General & Administrative was $21.62 million in Q2 2026, up 8.7% from $19.88 million a year earlier.
Powered by 
Analysis
Regenxbio (RGNX) Selling, General & Administrative (2014 - 2026) Analysis & Trends
On a trailing twelve-month basis, Regenxbio's Selling, General & Administrative was $84.13 million through Jun 30, 2026, up 5.6% year-over-year; for FY2025, it was $82.86 million, up 8.1% from FY2024.
- Selling, General & Administrative shows a five-year compound annual growth rate of 5.4% (FY2020 to FY2025).
- In earlier years, Selling, General & Administrative was $76.62 million in FY2024 (-13.4%), $88.49 million in FY2023 (+3.8%), $85.28 million in FY2022 (+7.5%) and $79.33 million in FY2021 (+24.3%).
- Quarterly Selling, General & Administrative has moved between $18.29 million (Q1 2024) and $23.7 million (Q2 2023) over five years.
- Compared with a year earlier, Selling, General & Administrative was higher in six of the last seven quarters, with growth averaging 4.4%.
- The best year-over-year quarter for Selling, General & Administrative over five years was Q3 2021 (growth of 32.6%); the worst was Q2 2024 (a decline of 20.4%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Regenxbio | 402.44 Mn | -530.65 Mn | - | 21.62 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 21.62 Mn |
| Dec 31, 2025 | 22.38 Mn |
| Sep 30, 2025 | 20.25 Mn |
| Jun 30, 2025 | 19.88 Mn |
| Mar 31, 2025 | 20.35 Mn |
| Dec 31, 2024 | 20.05 Mn |
| Sep 30, 2024 | 19.42 Mn |
| Jun 30, 2024 | 18.86 Mn |
| Mar 31, 2024 | 18.29 Mn |
| Dec 31, 2023 | 19.08 Mn |
| Sep 30, 2023 | 23.08 Mn |
| Jun 30, 2023 | 23.70 Mn |
| Mar 31, 2023 | 22.63 Mn |
| Dec 31, 2022 | 21.21 Mn |
| Sep 30, 2022 | 20.92 Mn |
| Jun 30, 2022 | 20.83 Mn |
| Mar 31, 2022 | 22.32 Mn |
| Dec 31, 2021 | 22.04 Mn |
| Sep 30, 2021 | 21.03 Mn |
| Jun 30, 2021 | 18.43 Mn |
API Access
Regenxbio Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=RGNX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "RGNX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=RGNX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();